Malaria vaccine study in study villages
Part of Infections clinical trials.
This study tests a new malaria vaccine (called R21/MM) given in different doses and forms. If you qualify, you'll help find a better way to protect against malaria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Live in one of the study villages for the whole 12-month study period
- Be between 14 and 60 years old
- Provide written consent (or parent/guardian consent if you are under 18)
- Not be pregnant, planning pregnancy within a month, or breastfeeding
- Never have had a malaria vaccine before
- Not be taking immunosuppressive drugs (like steroids, methotrexate) or involved in other trials
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether giving a malaria vaccine and a malaria drug together to whole villages in Bangladesh can help stop the spread of malaria and protect the entire community. It is open to nearly everyone living in selected villages, including children and adults.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
This trial tests a new malaria vaccine in healthy children. It aims to see if the vaccine is safe and how well it works in children who have had their regular childhood shots.
This study tests two different malaria vaccines to see which is safer and works better. Participants will receive one of the vaccines and then be exposed to a safe form of the malaria parasite to check if it protects them.
This study looks at whether malaria vaccines can also help lower the risk of a serious bacterial infection called invasive non-typhoidal Salmonella (iNTS). If you have a fever, you may be able to join and help researchers understand this connection.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.